Literature DB >> 28303814

Spoligotype defined lineages of Mycobacterium tuberculosis and drug resistance: Merely a casual correlation?

Nikita Panwalkar1, Devendra S Chauhan2, Prabha Desikan1.   

Abstract

Drug-resistant tuberculosis (TB) is a major challenge to TB control strategy worldwide. Analysis of genetic polymorphism among drug resistant Mycobacterium tuberculosis (MTB) strains may help provide some insight into the transmission dynamics of these strains. Spoligotyping is a widely used technique to identify genetic polymorphism, based on 43 known spacers interspersed between direct repeat regions. Considerable work has been done in various parts of the world using this technique to identify and analyse the polymorphic nature of MTB. Many studies have been carried out to determine the association of drug resistance with spoligotype defined lineages, and much data has been produced over the years. New information continues to be generated. This review aims to put together the findings of relevant studies in an attempt to understand the correlation of drug resistance with spoligotype defined lineages of MTB. This would help provide a perspective of the available data that can be used as a starting point to understand the molecular epidemiology of drug resistant TB.

Entities:  

Mesh:

Year:  2017        PMID: 28303814     DOI: 10.4103/0255-0857.202327

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  4 in total

1.  Line-probe assay and molecular typing reveal a potential drug resistant clone of Mycobacterium tuberculosis in Ethiopia.

Authors:  Shiferaw Bekele; Yohannes Derese; Stefan Berg; Abraham Aseffa; Elena Hailu; Adane Mihret; Kifle Dagne; Lawrence Yamuah; Tsegaye Hailu; Samuel Ayele; Demissew Beyene
Journal:  Trop Dis Travel Med Vaccines       Date:  2018-12-04

2.  Molecular Epidemiology of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in south Ethiopia.

Authors:  Yared Merid; Elena Hailu; Getnet Habtamu; Melaku Tilahun; Markos Abebe; Mesay Hailu; Tsegaye Hailu; Daniel Gemechu Datiko; Yimtubezinash Woldeamanuel; Abraham Aseffa
Journal:  J Infect Dev Ctries       Date:  2021-09-30       Impact factor: 0.968

3.  Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.

Authors:  Sara Al Mahrouqi; Amal Gadalla; Saleh Al Azri; Salama Al-Hamidhi; Amina Al-Jardani; Abdullah Balkhair; Amira Al-Fahdi; Laila Al Balushi; Samiya Al Zadjali; Asmahan Mohammed Nasser Al Marhoubi; Hamza A Babiker
Journal:  PeerJ       Date:  2022-07-28       Impact factor: 3.061

4.  Drug sensitivity of clinical isolates of Mycobacterium tuberculosis and its association with bacterial genotype in the Somali region, Eastern Ethiopia.

Authors:  Getnet Worku; Balako Gumi; Musse Girma; Binyam Mohammedbirhan; Getu Diriba; Getachew Seid; Melak Getu; Misikir Amare; Waganeh Sinshaw; Wondimu Ashagre; Rea Tschopp; Lauren Carruth; Gobena Ameni
Journal:  Front Public Health       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.